Work

Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement

Year: 2005

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Thrombosis and Haemostasis

DOI: 10.1111/j.1538-7836.2005.01657.x

Authors: B.I. ERIKSSON, L. BORRIS, O.E. DAHL, S. HAAS, M.V. HUISMAN, A.K. KAKKAR, F. MISSELWITZ, P. KÄLEBO

Institutions: Sahlgrenska University Hospital, Aarhus University Hospital, Thrombosis Research Institute, Leiden University Medical Center, Queen Mary University of London

Language: English

Topic: Venous Thromboembolism Diagnosis and Management

Subfield: Internal Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bayer, Bayer HealthCare

OpenAlex ID: W2066676409

FWCI: 25.79

Cites: 19

Cited by: 302

Related to: 10